糖心Vlog

For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Kazuhito Toyooka

Kazuhito Toyooka, PhD

Associate Professor


Department: Neurobiology & Anatomy

Education

  • PhD in Immunology - Osaka University, Japan
  • Shizuoka University, Japan

Other Languages Spoken

Japanese

Dr. Toyooka is an associate professor in the Department of Neurobiology & Anatomy at 糖心Vlog.

Research Interests

Translational research of autism spectrum disorder (ASD), epilepsy and Parkinson鈥檚 disease (PD) - Peptide therapy, CRISPR gene therapy, mouse models, patient-derived hiPSCs, gene functions in axon/dendrite outgrowth, spine/synapse formation, neural circuit/activity, and neurobehaviors including sociability, repetitive behavior, learning and memory

Research

Ongoing Projects

  • A translational study evaluating peptide therapy and CRISPR gene therapy as treatments for autism spectrum disorder (ASD).
  • 17p13.3 microdeletion (Miller-Dieker syndrome) and microduplication syndrome – Gene functions in the chromosome 17p13.3 region.
  • 14-3-3 syndromes - Understanding the etiology of neurological diseases associated with 14-3-3 gene mutations: Miller-Dieker syndrome, schizophrenia, neurodegenerative diseases, epilepsy.
  • Parkinson’s disease (PD) – Novel medication with 14-3-3 modifiers and interaction between α-Synuclein-14-3-3.

We are developing treatments for brain diseases, such as autism spectrum disorder (ASD) and Parkinson's disease (PD). We use three strategies to accomplish this goal: 1) Peptide therapy, 2) Gene therapy using CRISPR, and 3) 14-3-3 modifiers, in both mouse models and human iPSCs derived from patients.

1) A new medication for the treatment of autism spectrum disorder (ASD) as well as an understanding of the neurobiology of ASD.

Using mouse models of ASD and hiPSCs derived from patients with ASD, we investigate the peptides as a potential therapeutic to treat ASD. Additionally, we have developed gene therapy for ASD using CRISPR technology. Additionally, we are investigating the etiology of ASD, focusing on the neurobiology of the gene ADNP (Activity-Dependent Neuroprotective Protein), its role in axon/dendrite growth, spine/synapse formation, neuronal circuits and activity, and neurobehavior, including social interactions, repetitive behaviors, and learning and memory.

2) Understanding of the etiology of the 17p13.3 microdeletion and duplication syndrome.

We are currently investigating the etiology of neurodevelopmental disorders, including 17p13.3 deletion disorder (Miller-Dieker syndrome) associated with lissencephaly and 17p13.3 microduplication syndrome associated with autism.

3) Understanding of the etiology of epilepsy and cognition disorders caused by 14-3-3 gene mutations.

14-3-3 is a multifunctional protein that binds to more than 200 targets and acts as a scaffold protein. A mutation in the 14-3-3 gene, such as the YWHAG coding for the 14-3-3gamma protein, is associated with severe epilepsy. Also, a mutation or deletion of the YWHAE gene, which codes for the 14-3-3epsilon isoform, may result in epilepsy and defects in learning and memory. Our research focuses on understanding the etiology of these diseases, particularly whether mutated proteins function as loss-of-function or gain-of-function proteins.

4) Development of a new medication for Parkinson’s disease – 14-3-3 modifiers.

14-3-3 proteins bind to α-Synucleins and prevent the formation of α-Synuclein inclusions. We have investigated whether 14-3-3 modifiers could prevent the formation of α-Synuclein inclusions. Additionally, we have tested which 14-3-3 isoform is most effective in preventing the formation of synuclein inclusions. We also explore chemical compounds that may have the potential to be used as 14-3-3 modifiers, which may lead to the development of new medications.

Toyooka: In utero electroporation multiple genes expression; Primary cortical neuron culture; In utero electroporation cell staining

Toyooka: Thy 1 YFP mouse; In utero electroporation; In vitro neuronal migration assay

Current lab personnel:

  • Neetika Mishra: Undergraduate research assistant at Drexel
  • Christine Deng: MD student at Drexel
  • Lilit Drak: MD student at Drexel
  • Diane Kim: MS candidate at 糖心Vlog
  • Samridhi Sudan: STAR scholar and an undergraduate research assistant at Drexel
  • Laasya Reddy Pesaladinne: High school student intern
  • Shiena Watanabe, MD: Postdoctoral Fellow
  • Vicky Shih: MD-PhD student at Drexel
  • William R. Telfer: MD student at Drexel
  • Vasu: MD student at Drexel

Past lab personnel:

  • Sierra Coleman: PhD candidate in Neuroscience Program
  • Emily Taylor: An undergraduate volunteer
  • Sara Shigambayeva: An undergraduate student at 糖心Vlog
  • Jiwoo Lee: A high school student intern
  • Carrie Gordon: undergraduate student (STAR program)
  • Bijaya Manandhar: undergraduate student
  • Xiaonan Liu: PhD candidate
  • Cayla Andrews: MS candidate
  • Sarah Bennison: PhD candidate
  • Sara Blajezewski: PhD candidate
  • Lozen Robinson: undergraduate student (STAR program)
  • Brett T. Cornell: PhD
  • Thomas Sibert: MD student
  • Trevor Smith: research assistant
  • Tomoka Wachi, PhD: postdoctoral fellow

Publications

Peer-Reviewed Manuscripts


Toyo-oka, K. (Book Editor)
Methods in Molecular Biology, Springer Nature, 2024


Liu, X., Toyo-Oka, K.
Neuronal Morphogenesis: Methods and Protocols, Methods in Molecular Biology, 2024, 199-208


Sun X., Yu W., Baas P., Toyo-oka K., Qiang L.
J. Cell Sci, 2024, 137(19): jcs261966


Bennison, S.A., Blazejewski, S.M., Liu, X., Hacohen-Kleiman, G., Sragovich, S., Zoidou, S., Touloumi, O., Grigoriadis, N., Gozes, I. and Toyo-oka, K.
Mol. Psychiatry. 2023, 28 (5), 1829


Bennison SA, Blazejewski, SM, Liu X, Hacohen-Kleiman G, Sragovich S, Zoidou S, Touloumi O, Grigoriadis N, Gozes I and Toyo-oka K
Mol. Psychiatry. 2023, 28 (5), 1946-1959

Additional publications...

Radler MR, Liu X, Peng M, Doyle B, Toyo-oka K and Spiliotis ET
Curr. Biol., 2022, 33 (3), 434-448. e8


Bennison SA, Liu X and Toyo-oka K
Cell. Signal., (2022) 100: 110472, doi: 10.1016/j.cellsig.2022.110472

鈥淜IFC1 regulates the trajectory of neuronal migration鈥
Muralidharan, H., Guha, S., Madugula, K., Patil, A., Bennison, S.A., Sun, X., Toyo-oka, K., and Baas, A.
J Neurosci., 2022, 41(11): 2149-2165

鈥淩psa signaling regulates cortical neuronal morphogenesis via its ligand, PEDF, and plasma membrane interaction partner, Itga6鈥
Blazejewski, S.M., Bennison, S.A., Ha, N., Liu, X., Smith, T.H., Dougherty, K. J., and Toyo-oka, K.
Cereb. Cortex, 2022, 32: 770-795


Liu, X., Bennison, S.A., Robinson, L., and Toyo-oka, K.
Brain Sci. 2022, 12(1), 56

鈥淭NFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity鈥
Fu, W., Hu, W., Yi, Y.-S., Hettinghouse, A., Sun, G., Bi, Y., He, W., Zhang, L., Gao, G., Liu, J., Toyo-oka, K., Xiao, G., Solit, D.B., Loke, P., and Liu, C.-J.
J. Clin. Invest. 2021, 131(16): e144016

鈥淗igh-Throughput Kinase Inhibitor Screening Reveals Roles for Aurora and Nuak Kinases in Neurite Initiation and Dendritic Branching鈥
Blazejewski, S.M., Bennison, S.A., Liu, X. and Toyo-oka, K.
Sci Rep, 2021, 11(1):8156

鈥淕lutathione S-transferase Pi (Gstp) Proteins Regulate Neuritogenesis in the Developing Cerebral Cortex鈥
Liu, X., Blazejewski, S.M., Bennison, S.A. and Toyo-oka, K.
Hum. Mol. Genet, 2021, 30(1):30-45

鈥淧rotein kinases: master regulators of neuritogenesis and therapeutic targets for axon regeneration鈥
Bennison SA, Blazejewski SM, Smith TH, Toyo-oka K
Cell Mol Life Sci. (2019) Oct 28. doi: 10.1007/s00018-019-03336-6

"Methionine sulfoxide reductase A (MsrA) mediates the ubiquitination of 14-3-3 protein isotypes in brain."
Deng Y, Jiang B, Rankin CL, Toyo-oka K, Richter ML, Maupin-Furlow JA, Moskovitz
J. Free Radic Biol Med. 2018, 129: 600-607.

鈥淣eurodevelopmental Genetic Diseases Associated with Microdeletions and Microduplications of Chromosome 17p13.3鈥
Blajezewski SM, Bennison SA, Smith TH and Toyo-oka K
Front. Genet. 9:80 (2018) doi: 10.3389/fgene.2018.00080


Cornell B and Toyo-oka K
Front. Mol. Neurosci, 2017, 12 October 2017,

"Complete ablation of the 14-3-3epsilon protein results in multiple defects in neuropsychiatric behaviors."
Wachi T, Cornell B and Toyo-oka K
Behav Brain Res, 2017, 319: 31-36.

"Deficiency of 14-3-3ε and 14-3-3ζ by the Wnt1 promoter-driven Cre recombinase results in pigmentation defects"
Cornel B and Toyo-oka K
BMC Res Notes, 9(1);180-185, 2016

"In vitro and in vivo Analysis of 14-3-3epsilon and the Regulation of Neuronal Morphogenesis via the Microtubule Binding Protein, Doublecortin."
Cornell B, Wachi T, Zhukarev V and Toyo-oka K
Hum Mole Genet, 2016, 25(20): 4405-4418.

"Overexpression of the 14-3-3Gamma Protein in Embryonic Mice Results in Neuronal Migration Delay in the Developing Cerebral Cortex"
Cornell B, Wachi T, Zhukarev V and Toyo-oka K
Neurosci Lett, in press, doi:10.1016/j.neulet.2016.06.009.

"Ablation of the 14-3-3gamma Protein Results in Neuronal Migration Delay and Morphological Defects in the Developing Cerebral Cortex"
Wachi T, Cornell B, Marshall C, Zhukarev V, Baas PW, and Toyo-Oka K
Dev Neurobiol., 76 (6): 600-614, 2016

"Novel Functions of 14-3-3 Proteins in Neurogenesis and Neuronal Differentiation In Vivo"
Wachi T and Toyo-oka K
Ther Targets Neurol Dis (Therapeutic targets for neurological diseases), 2015, 2(1), doi: 10.14800/ttnd.500

"14-3-3epsilon and zeta Regulate Neurogenesis and Differentiation of Neuronal  Progenitor Cells in the Developing Brain""
Toyo-oka K, Wachi T, Hunt RF, Baraban SC, Taya S, Ramshaw H, Kaibuchi K,  Schwarz QP, Lopez AF and Wynshaw-Boris A
J Neurosci., 34(36):12168-12181, 2014

"14-3-3{varepsilon} Plays a Role in Cardiac Ventricular Compaction by Regulating the Cardiomyocyte Cell Cycle"
Kosaka Y, Cieslik KA, Li L, Lezin G, Maguire CT, Saijoh Y, Toyo-Oka K, Gambello MJ, Vatta M, Wynshaw-Boris A, Baldini A, Yost HJ and Brunelli L
Mol. Cell. Biol., 32:5089-5102, 2012

"Neurodevelopmental defects and neuropsychiatric behaviour arise from 14-3-3zeta deficiency"
Cheah PS, Ramshaw HS., Thomas PQ, Toyo-oka K, Martin S, Coyle P, Guthridge MA, Stomski F, van den Buuse M, Wynshaw-Boris A, Lopez AF and Schwarz QP
Mol. Psychiatr., 17:451-466, 2011

"Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia"
Ikeda M, Hikita T, Taya S, Uraguchi-Asaki J, Toyo-oka K, Wynshaw-Boris A, Ujike H, Inada T, Takao K, Miyakawa T, Osaki N, Kaibuchi K and Iwata N
Hum. Mol. Genet., 17: 3212-3222, 2008

"A Neuroepithelial Stem Cell Proliferation requires LIS1 for Precise Spindle Orientation and Symmetric Division"
Yingling J, Youn YH, Darling D, Toyo-oka K, Pramparo T, Hirotsune S and Wynshaw-Boris
Cell, 132: 474-486, 2008

"Protein Phosphatase4 catalytic subunit (PP4c) regulates CDK1 activity and organization of microtubules through dephosphorylation of NDEL1"
Toyo-oka K, Yano Y, Shiota M, Iwao H, Hiraiwa N, Muramatsu M, Yoshiki A and Hirotsune S
J Cell Biol., 180: 1133-1147, 2008

"NDEL1 Phosphorylation by Aurora-A Kinase Is Essential for Centrosomal Maturation, Separation, and TACC3 recruitment"
Mori D, Yano Y, Toyo-oka K, Yoshida N, Yamada M, Muramatsu M, Zhang D, Saya H, Toyoshima YY, Kinoshita K, Wynshaw-Boris A and Hirotsune S
Mol. Cell. Biol., 27: 352-367, 2007

"Mnt-Deficient Mammary Glands Exhibit Impaired Involution and Tumors with Characteristics of Myc Overexpression"
Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Lozach LE, Bassett IG, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin PJ and Wynshaw-Boris A
Cancer Res., 66: 5565-5573, 2006

"Recruitment of katanin P60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration"
Toyo-oka K, Sasaki S, Yano Y, Mori D, Kobayashi T, Toyoshima YY, Tokuoka SM, Ishii S, Shimizu T, Muramatsu M, Hiraiwa N, Yoshiki A, Wynshaw-Boris A and Hirotsune S
Hum. Mol. Genet., 14: 3113-3128, 2005

"Complete Loss of Ndel1 Results in Neuronal Migration Defects and Early Embryonic Lethality"
Sasaki S, Mori D, Toyo-oka K, Chen A, Garrett-Beal L, Muramatsu M, Miyagawa S, Hiraiwa N, Yoshiki A, Wynshaw-Boris A, and Hirotsune A
Mol. Cell. Biol., 25:7812-7827, 2005

"Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome"
Toyo-oka K, Hirotsune S, Gambello MJ, Zhou Z-Q, Olson L, Rosenfeld MG, Eisenman R, Hurlin PJ and Wynshaw-Boris A
Hum. Mol. Genet., 13:1057-1067, 2004

"Evidence of Mnt-Myc Antagonism Revealed by Mnt Gene Deletion"
Hurlin PJ, Zhou Z-Q, Toyo-oka K, Ota S, Walker WL, Hirotsune S and Wynshaw-Boris A
Cell Cycle, 3:97-99, 2004

"Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis"
Hurlin PJ, Zhou Z-Q, Toyo-oka K, Ota S, Walker WL, Hirotsune S and Wynshaw-Boris A
EMBO J., 22:4584-4596, 2003

"Miller-Dieker Syndrome: Analysis of a Human Contiguous Gene Syndrome in the Mouse"
Yingling J, Toyo-oka K, and Wynshaw-Boris A
Am. J. Hum. Genet., 73(3):475-488, 2003

"14-3-3epsilon is important for neuronal migration via binding of NUDEL : a molecular explanation for Miller-Dieker syndrome"
Toyo-oka K, Shionoya A, Gambello MJ, Cardoso C, Leventer R, Ward HL, Ayala R, Tsai L-H, Dobyns W, Ledbetter D, Hirotsune S and Wynshaw-Boris A
Nat. Genet., 34:274-285, 2003

"Refinement of a 400-kb Critical Region Allows Genotypic Differentiation between Isolated Lissencephaly, Miller-Dieker Syndrome, and Other Phenotypes Secondary to Deletions of 17p13.3"
Cardoso C, Leventer RJ, Ward HL, Toyo-oka K, Chung J, Gross A, Martin CL, Allanson J, Pilz DT, Olney AH, Mutchinick OM, Hirotsune S, Wynshaw-Boris A, Dobyns WB and Ledbetter DH
Am. J. Hum. Genet., 72:918-930, 2003


Contact Information


Department of Neurobiology & Anatomy
2900 W. Queen Lane, Room 186
Philadelphia, PA 19129
Phone: 215.991.8288